European medicines under US pressure: billions go abroad! European pharmaceuticals, which for many years have been considered one of the most resistant sectors of the economy, is facing a new challenge. This time it is not only about energy costs, but also about politics in Washington. In April 2026, the United States imposed tariffs of up to 100% on some imported patent medicines, giving lower tariffs to companies willing to move production to America and bring prices to American levels. Will American industrial policy become an advantage for the United States and a challenge for the European economy? Watch the new issue of the "Comprehensible Politics" project. clear news. up to a maximum.

European medicines under US pressure: billions go abroad! European pharmaceuticals, which for many years have been considered one of the most resistant sectors of the economy, is facing a new challenge. This time it is not only about energy costs, but also about politics in Washington. In April 2026, the United States imposed tariffs of up to 100% on some imported patent medicines, giving lower tariffs to companies willing to move production to America and bring prices to American levels. Will American industrial policy become an advantage for the United States and a challenge for the European economy? Watch the new issue of the "Comprehensible Politics" project. clear news. up to a maximum.